May 6, 2014 — (BRONX, NY) — Healthy stem cells work to restore or repair the body’s tissues, but cancer stem cells have a more nefarious mission: to spawn malignant tumors. Cancer stem cells were discovered a decade ago, but their origins and identity remain largely unknown.
Paul Frenette, M.D.On Tuesday, May 13, the Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research at Albert Einstein College of Medicine of Yeshiva University will host its second Stem Cell Symposium, focusing on cancer stem cells. Leading scientists from the U.S., Canada and Belgium will discuss the latest advances in the field and highlight the challenges of translating this knowledge into targeted cancer treatments.
"These exceptional scientists are pioneers in the field and have made enormous contributions to our understanding of the biology of stem cells and cancer," said Paul Frenette, M.D., director and chair of Einstein's Stem Cell Institute and professor of medicine and of cell biology. "We look forward to discussing the latest developments. Hopefully it will spark productive dialogues and collaborations among the researchers who attend."
The symposium will take place in the afternoon, from 1:00 – 5:30 p.m. ET. The scheduled presenters are:
"These exceptional scientists are pioneers in the field and have made enormous contributions to our understanding of the biology of stem cells and cancer."
– Paul Frenette, M.D.
9/11 World Trade Center Exposure Linked to Heart Disease Among NYC Firefighters
On Becoming a Physician: New Einstein Students Receive White Coats and Stethoscopes
Novel Therapy for Acute Migraine Shows Promise in Phase 3 Clinical Trial
First Complete Wiring Diagram of an Animal's Nervous System
Multimillion Dollar NIH Grant to Help Reduce Opioid Use & Get Care to People Who Need It
NIH Grant Funds $23 Million Study of Diseases Affecting People Living with HIV
New TAILORx Data Guides Adjuvant Therapy in Younger Breast Cancer Patients
Einstein Celebrates Its 61st Commencement
Bolstering Biopsies: Testing Patients' Individual Cells to Guide Treatment
Tablet Blog